The Lancet Gastroenterology & Hepatology Journal Cover May 1st 2017
figureposted on 2017-12-06, 12:12 authored by Andrew SelbyAndrew Selby
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the EU, treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a more than 65% reduction in liver-related deaths, a more than 90% reduction of new viral hepatitis infections, and more than 90% of patients being diagnosed with viral hepatitis infections by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination.
Dr Robert Brierley, Dr Heather Van Epps
- The Arts, English and Drama
CitationSELBY, A., 2017. The Lancet Gastroenterology & Hepatology Journal Cover May 1st 2017. The Lancet Gastroenterology & Hepatology Journal, 2(5).
- VoR (Version of Record)
Publisher statementThis work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
NotesThis paper was accepted for publication in the journal The Lancet Gastroenterology & Hepatology Journal and the definitive published version is available at http://www.thelancet.com/journals/langas/issue/vol2no5/PIIS2468-1253(17)X0004-6.